Insider Transactions Reported by 16 Insiders of Immuneering Corp

Symbol
IMRX on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Immuneering Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Benjamin J. Zeskind PRESIDENT AND CEO, Director $9,928,137 +$85,023 +0.86% 03 Feb 2026
Cormorant Asset Management, LP 10%+ Owner $8,598,961 01 Apr 2024
Peter Feinberg Director $6,947,380 +$288,747 +4.3% 12 Jan 2026
Brett Matthew Hall Chief Scientific Officer $1,720,586 +$45,118 +2.7% 03 Feb 2026
Thomas J. Schall Director $347,913 +$225,107 +183% 15 Jan 2026
Mallory Morales SVP Finance, CAO $175,935 +$1,917 +1.1% 03 Feb 2026
Leah R. Neufeld Chief People Officer $145,918 +$18,508 +15% 13 Mar 2026
Harold E. Brakewood Chief Business Officer $52,598 +$29,794 +131% 03 Feb 2026
Michael D. Bookman Chief Legal Officer, Secretary $33,261 +$6,966 +26% 03 Feb 2026
Biren Amin Cfo, Treasurer $23,773 12 May 2022
Diana F. Hausman Director $19,862 +$19,863 02 Jul 2025
Laurie B. Keating Director 01 Jan 2026
CARPENTER ROBERT J Director 13 Jun 2025
Igor Matushansky Chief Medical Officer 03 Feb 2026
Ann E. Berman Director 13 Jun 2025
Scott Barrett Chief Medical Officer 15 Feb 2023

Recent Insider Transactions by Companies or Individuals for Immuneering Corp

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Leah R. Neufeld IMRX Class A Common Stock Award 14% 3,628 29,598 13 Mar 2026 Direct
Michael D. Bookman IMRX Stock Option Award 176,000 176,000 03 Feb 2026 Direct
Harold E. Brakewood IMRX Stock Option Award 140,000 140,000 03 Feb 2026 Direct
Brett Matthew Hall IMRX Stock Option Award 344,000 344,000 03 Feb 2026 Direct
Mallory Morales IMRX Stock Option Award 140,000 140,000 03 Feb 2026 Direct
Leah R. Neufeld IMRX Stock Option Award 140,000 140,000 03 Feb 2026 Direct
Benjamin J. Zeskind IMRX Stock Option Award 688,000 688,000 03 Feb 2026 Direct
Igor Matushansky IMRX Stock Option Award 140,000 140,000 03 Feb 2026 Direct
Harold E. Brakewood IMRX Class A Common Stock Purchase 90.5% $24,990 $4.76 5,250 11,050 16 Jan 2026 Direct
Thomas J. Schall IMRX Class A Common Stock Purchase 40.9% $101,041 $4.67 21,645 74,530 15 Jan 2026 Direct
Brett Matthew Hall IMRX Class A Common Stock Purchase 0.61% $10,502 $4.57 2,298 376,496 15 Jan 2026 Direct
Leah R. Neufeld IMRX Class A Common Stock Purchase 11.2% $10,906 $4.15 2,626 25,970 13 Jan 2026 Direct
Peter Feinberg IMRX Class A Common Stock Purchase 17.3% $86,904 $4.35 20,000 135,441 12 Jan 2026 General Partner of S4K Investments LLC.
Laurie B. Keating IMRX Stock Option Award 7,888 7,888 01 Jan 2026 Direct
Peter Feinberg IMRX Stock Option Award 7,888 7,888 01 Jan 2026 Direct
Peter Feinberg IMRX Class A Common Stock Purchase 5.02% $50,025 $6.67 7,500 156,766 03 Oct 2025 Direct
Mallory Morales IMRX Class A Common Stock Purchase 1.1% $1,917 $6.39 300 27,533 01 Oct 2025 Direct
Leah R. Neufeld IMRX Class A Common Stock Purchase 3.55% $5,103 $6.38 800 23,344 01 Oct 2025 Direct
Michael D. Bookman IMRX Class A Common Stock Purchase 26.5% $6,966 $6.83 1,020 4,870 01 Oct 2025 Direct
Peter Feinberg IMRX Class A Common Stock Purchase 5.29% $52,730 $7.03 7,500 149,266 30 Sep 2025 Direct
Peter Feinberg IMRX Class A Common Stock Purchase 3.66% $35,900 $7.18 5,000 141,766 29 Sep 2025 Direct
Leah R. Neufeld IMRX Class A Common Stock Award 110.1% 11,815 22,544 15 Sep 2025 Direct
Mallory Morales IMRX Class A Common Stock Award 113.8% 14,497 27,233 15 Sep 2025 Direct
Brett Matthew Hall IMRX Class A Common Stock Award 4.14% 14,880 374,198 15 Sep 2025 Direct
Diana F. Hausman IMRX Class A Common Stock Purchase $10,874 $3.62 3,000 3,000 02 Jul 2025 By spouse
Diana F. Hausman IMRX Class A Common Stock Purchase $8,989 $3.60 2,500 2,500 02 Jul 2025 Direct
Leah R. Neufeld IMRX Class A Common Stock Purchase 6.98% $2,499 $3.57 700 10,729 02 Jul 2025 Direct
Benjamin J. Zeskind IMRX Class A Common Stock Purchase 0.3% $24,792 $3.53 7,015 2,312,852 02 Jul 2025 Direct
Benjamin J. Zeskind IMRX Class A Common Stock Purchase 0.13% $10,087 $3.38 2,985 2,305,837 01 Jul 2025 Direct
Thomas J. Schall IMRX Class A Common Stock Purchase 21.9% $34,788 $3.66 9,500 52,885 27 Jun 2025 Direct
Brett Matthew Hall IMRX Class A Common Stock Purchase 1.7% $14,596 $2.43 6,007 359,318 23 Jun 2025 Direct
Brett Matthew Hall IMRX Class A Common Stock Purchase 2.14% $20,020 $2.70 7,415 353,311 20 Jun 2025 Direct
Harold E. Brakewood IMRX Class A Common Stock Purchase 48.7% $4,804 $2.53 1,900 5,800 20 Jun 2025 Direct
Peter Feinberg IMRX Class A Common Stock Purchase 22.4% $63,188 $2.53 25,000 136,766 18 Jun 2025 Direct
Benjamin J. Zeskind IMRX Class A Common Stock Purchase 0.92% $50,144 $2.39 21,000 2,302,852 18 Jun 2025 Direct
Thomas J. Schall IMRX Class A Common Stock Purchase 1396% $89,278 $2.21 40,485 43,385 17 Jun 2025 Direct
Diana F. Hausman IMRX Stock Option Award 33,350 33,350 13 Jun 2025 Direct
Thomas J. Schall IMRX Stock Option Award 33,350 33,350 13 Jun 2025 Direct
Laurie B. Keating IMRX Stock Option Award 33,350 33,350 13 Jun 2025 Direct
Peter Feinberg IMRX Stock Option Award 33,350 33,350 13 Jun 2025 Direct
Carpenter Robert J IMRX Stock Option Award 33,350 33,350 13 Jun 2025 Direct
Ann E. Berman IMRX Stock Option Award 33,350 33,350 13 Jun 2025 Direct
Igor Matushansky IMRX Stock Option Award 118,000 118,000 21 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.